GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ODI Pharma AB (XSAT:ODI) » Definitions » Gross Profit

ODI Pharma AB (XSAT:ODI) Gross Profit : kr4.37 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is ODI Pharma AB Gross Profit?

ODI Pharma AB's gross profit for the three months ended in Dec. 2024 was kr0.00 Mil. ODI Pharma AB's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was kr4.37 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. ODI Pharma AB's gross profit for the three months ended in Dec. 2024 was kr0.00 Mil. ODI Pharma AB's Revenue for the three months ended in Dec. 2024 was kr0.00 Mil. Therefore, ODI Pharma AB's Gross Margin % for the quarter that ended in Dec. 2024 was N/A%.

ODI Pharma AB had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage

During the past 6 years, the highest Gross Margin % of ODI Pharma AB was 20.73%. The lowest was -516.55%. And the median was -33.23%.


ODI Pharma AB Gross Profit Historical Data

The historical data trend for ODI Pharma AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ODI Pharma AB Gross Profit Chart

ODI Pharma AB Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Gross Profit
Get a 7-Day Free Trial - - -0.10 -0.72 4.62

ODI Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 2.72 1.51 0.14 -

Competitive Comparison of ODI Pharma AB's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ODI Pharma AB's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where ODI Pharma AB's Gross Profit falls into.


;
;

ODI Pharma AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

ODI Pharma AB's Gross Profit for the fiscal year that ended in Jun. 2024 is calculated as

Gross Profit (A: Jun. 2024 )=Revenue - Cost of Goods Sold
=22.286 - 17.665
=4.62

ODI Pharma AB's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.37 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

ODI Pharma AB's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


ODI Pharma AB  (XSAT:ODI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ODI Pharma AB had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


ODI Pharma AB Gross Profit Related Terms

Thank you for viewing the detailed overview of ODI Pharma AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


ODI Pharma AB Business Description

Traded in Other Exchanges
N/A
Address
Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.

ODI Pharma AB Headlines

No Headlines